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Effects of Breastfeeding on Respiratory Symptoms in Infancy
Olga Gorlanova, MD1,*, Simone Thalmann, MD1,*, Elena Proietti, MD1,2, Georgette Stern, PhD2, Philipp Latzin, MD, PhD1,2,
Claudia K€uhni, MD, PhD3, Martin Ro€€osli, PhD4, and Urs Frey, MD, PhD1
Objective To assess the impact of potential risk factors on the development of respiratory symptoms and their 
specific modification by breastfeeding in infants in the first year of life.
Study design We prospectively studied 436 healthy term infants from the Bern-Basel Infant Lung Development 
cohort. The breastfeeding status, and incidence and severity of respiratory symptoms (score) were assessed
weekly by telephone interview during the first year of life. Risk factors (eg, pre- and postnatal smoking exposure,
mode of delivery, gestational age, maternal atopy, and number of older siblings) were obtained using standardized
questionnaires. Weekly measurements of particulate matter <10 mg were provided by local monitoring stations. The
associations were investigated using generalized additive mixed model with quasi Poisson distribution.
Results Breastfeeding reduced the incidence and severity of the respiratory symptom score mainly in the first 
27 weeks of life (risk ratio 0.70; 95% CI 0.55-0.88). We found a protective effect of breastfeeding in girls but not
in boys. During the first 27 weeks of life, breastfeeding attenuated the effects of maternal smoking during preg-
nancy, gestational age, and cesarean delivery on respiratory symptoms. There was no evidence for an interaction
between breastfeeding and maternal atopy, number of older siblings, child care attendance, or particulate matter
<10 mg.
Conclusions This study shows the risk-specific effect of breastfeeding on respiratory symptoms in early life 
using the comprehensive time-series approach.
A
cute respiratory infection is a major cause of morbidity and hospitalization among young children worldwide. Several
hereditary risk factors,1,2 perinatal factors,3-5 factors associated with immune development (maternal atopy, asthma),6,7
as well as environmental factors are known to increase the risk of lower respiratory tract disease in infants. Pre- and
postnatal maternal smoking, and environmental exposure to particulate matter <10 mg (PM10) and nitrogen dioxide, are corre-
lated with more respiratory symptoms in the first year of life.1,8,9
Breastfeeding is generally accepted to be protective against respiratory symptoms in early life.2,10-14 Furthermore, growing
knowledge indicates that breastfeeding may differentially affect susceptible subgroups. A number of studies found evidence
of a protective effect of breastfeeding against respiratory infection, particularly in the first 4-6 months of life.2,10,12-15 Other
studies have reported a protective effect of breastfeeding only in girls16-18 and in the first born child.19 Some studies have sug-
gested that breastfeeding reduced the adverse effects of smoking20-22 and air pollution20 exposure on respiratory morbidity.
However, most studies are cross-sectional16,17,20,22,23 and, therefore, prone to bias, due to the close concordance of lifestyle fac-
tors and socioeconomic status, which relate to smoking rates, inhabiting polluted areas, and breastfeeding. In developed coun-
tries, breastfeeding mothers tend to have a higher education status and smoke less.24,25 Moreover, it is unknown whether
breastfeeding may favorably influence the association of respiratory symptoms with the mode of delivery and gestational age.
We hypothesize that the protective effect of breastfeeding might be specifically modified dependent on the nature of the
exposure to hereditary, perinatal, or environmental risk factors. In order to test our hypothesis, we aim to investigate whether
breastfeeding can modify the relationship of respiratory symptoms with age, hereditary risk factors (sex, maternal atopy, and
maternal asthma), perinatal factors (gestational age and cesarean delivery), and environmental factors (PM10, prenatal andFrom the 1University Children’s Hospital (UKBB),
University of Basel, Basel, Switzerland; 2Pediatric
Respiratory Medicine, Inselspital and University of Bern;
3Institute of Social and Preventive Medicine (ISPM),
University of Bern, Bern, Switzerland; and 4Swiss
Tropical and Public Health Institute, University of Basel,
Basel, Switzerlandpostnatal tobacco exposure, number of older siblings, and child care attendance)
within the prospective Bern-Basel Infant Lung Development (BILD) birth cohort
study from Switzerland. We look at these effects in healthy term infants, using a
statistical time series approach that accounts for breastfeeding status and
environmental air pollutant exposure on a week-by-week basis. The novelty of
our approach is that we made comparisons within the same child on a weekly
basis, so the effect of common confounders was minimized.*Contributed equally.
Supported by the Swiss National Science Foundation
(324730_144280). The authors declare no conflicts of
interest.
Portions of the study were presented as a poster at the
European Respiratory Society conference, September 7-
11, 2013, Barcelona, Spain.
BILD Bern-Basel Infant Lung Development
GAMM Generalized additive mixed model
PM10 Particulate matter <10 mg
RR Risk ratio
Published in final edited form as: J Pediatr. 2016 Jul;174:111-117.e5. doi: 10.1016/j.jpeds.2016.03.041Methods
Data was taken from the ongoing prospective BILD birth
cohort study26 and included 436 unselected healthy new-
borns born in Bern, Switzerland between April 1999 and
November 2013, with complete information about breast-
feeding status. Recruitment, and inclusion and exclusion
criteria are described elsewhere.1,26 Written consent was ob-
tained from all parents, and the Ethics Committees of the Re-
gions of Basel and Bern approved the study.
Outcome
As previously described,1,8,26,27 respiratory symptoms (cough,
wheezing, and difficulty breathing) were collected in weekly
telephone interviews conducted by study nurses using a stan-
dardized symptom score (Table I; available at www.jpeds.
com) with high sensitivity for lower respiratory tract
infection and particularly reflects the burden of disease and
health care utilization. Day and night time respiratory
symptom scores range from 0-4, with scores $3 indicating
severe symptoms (eg, repeated sleep disturbances, admission
to hospital, or general practitioner called). The outcome was
the overall symptom score calculated as the sum of day and
night-time symptom scores (total possible range 0-8).
Breastfeeding
Mothers were asked weekly about their breastfeeding status
until they completely stopped breastfeeding. Any breastfeed-
ing was defined as exclusive breastfeeding, or receiving breast
milk and other solids or liquids, and was treated as a binary
time-dependent variable (yes or no for each week under obser-
vation). Because supplementation with formula and the intro-
duction of solids were not regularly assessed in a standardized
manner, these factors were not considered for further analysis.
Risk Factors
Detailed information on risk factors was obtained either at
enrollment or during the weekly telephone interviews using
a standardized questionnaire described elsewhere.26 Risk fac-
tors included maternal history of atopy (defined as either
atopic asthma, atopic rhinitis, or atopic dermatitis), mode
of delivery (vaginal or cesarean delivery), parental educa-
tional level (low = less than 4 years of apprenticeship;
middle = at least 4 years of apprenticeship, and
high = tertiary education) as a marker of socioeconomic sta-
tus, number of older siblings (0, 1, and$2), child care atten-
dance, maternal smoking during pregnancy, postnatal
parental smoking, and housing conditions. Cotinine levels
were tested in the first urine to validate maternal smoking
status. Average weekly air pollution levels in the week preced-
ing the interview were quantitatively measured and modeled,
as previously described.8
Statistical Analyses
Time-series data for each child consisted of weekly measures
of respiratory symptom score, breastfeeding status, and time-
dependent variables (eg, week of age, PM10 exposure, tem-perature, and week of study [includes seasonal variation])
(Figure 1; available at www.jpeds.com). The smooth
(nonlinear) function of week of study also allowed us to
control for unmeasured time-varying confounders such as
flu epidemics. Respiratory symptom scores with a large
number of zeroes (ie, weeks without respiratory symptoms)
had an overdispersed Poisson distribution with a mean
greater than a variance. Thus, we analyzed data using the
generalized additive mixed model (GAMM) with quasi-
Poisson distribution allowing for overdispersion. To
account for possible temporal correlation among
respiratory symptoms within each child we included an
autoregressive structure with lag 1.
We first investigated the relationship between the respira-
tory symptom score and each exposure of interest adjusting
only for week of study (includes seasonal variation), and
week of age (simple model). We then adjusted (adjusted
model) for exposures of interest and known confounders:
sex, birth weight, gestational age, mode of delivery, maternal
atopy, number of older siblings, child care attendance,
maternal smoking during pregnancy, maternal education,
distance to major roads, weekly average of temperature,
week of study, week of age, and weekly average of PM10. In
order to assess the potential effect of modification by breast-
feeding on the association between age, perinatal, environ-
mental, hereditary risk factors, and respiratory symptoms,
we fitted separate regression models by breastfeeding status.
We included in the adjusted models the multiplicative inter-
action term between breastfeeding and exposure of interest to
calculate P value for interaction.
We then repeated the analysis focusing on the first 27 weeks
of life. We chose this as the cut-off because it is the median in
age distribution in our study sample, and because the protec-
tive effect of breastfeeding is stronger in younger infants.
Figure 2 (available at www.jpeds.com) summarizes the
statistical strategy.
In the sensitivity analysis, we selected infants without
maternal smoking exposure during pregnancy (N = 402) in
order to examine the effect of parental postnatal smoking
exposure on respiratory morbidity and its modification by
breastfeeding.
Estimates were expressed as a risk ratio (RR) with 95% CI.
We calculated P trend values by applying post hoc ANOVA
test. All analyses were performed with R (v 3.0.1) using
mgcv package.28,29 A P value below .05 was considered to
be significant.Results
We studied 436 unselected healthy infants with complete in-
formation about their breastfeeding status from the BILD
birth cohort study. Population statistics are described in
Table II. Results from both the simple and adjusted models
for the overall respiratory symptom score during first
27 weeks, and first year, of life are summarized in
Tables III and IV (Table IV; available at www.jpeds.com),
Published in final edited form as: J Pediatr. 2016 Jul;174:111-117.e5. doi: 10.1016/j.jpeds.2016.03.041respectively. The stratified analysis by breastfeeding and sex
with P value for interaction are displayed in Tables V-VIII
(Tables VI-VIII; available at www.jpeds.com). Additional
results are available in the Appendix (available at www.
jpeds.com).
Over the first 12 months, breastfeeding was not signifi-
cantly associated with the respiratory symptom score, in
either the simple or adjusted models (Table IV). However,
a significant correlation between respiratory symptoms and
breastfeeding was found in the first 6 months of life
(Table III).
GAMM analysis showed a significant nonlinear associa-
tion between week of age and respiratory symptoms in the
first year of life (P value of <.001). The overall symptom score
increased, mainly during the first 27 weeks. After that point,
the symptom score did not change considerably (Figure 3;
available at www.jpeds.com).Table II. Characteristics of the study population
(N = 436)
Summary statistics
Anthropometrics
Boys, n (%) 235 (53.9%)
Birth weight, mean (SD), kg 3.4 (0.4)
Length, mean (SD), cm 49 (2.0)
Gestational age, mean (SD), wk 39.8 (1.1)
Respiratory symptoms, mean (SD)
1 y of life
Wk with overall symptoms 5.07 (4.8)
Overall respiratory symptom score 0.25 (0.9)
27 wk of life
Wk with overall symptoms 1.5 (2.2)
Overall respiratory symptom score 0.13 (0.6)
Duration of breastfeeding (wk)
Breastfeeding, mean (SD) 34.7 (15.2)
Boys, mean (SD) 33.9 (15.2)
Girls, mean (SD) 35.7 (15.2)
No maternal smoking in pregnancy, mean (SD) 25.8 (16.4)
Maternal smoking in pregnancy, mean (SD) 35.7 (14.8)
Vaginal delivery, mean (SD) 34.5 (15.4)
Caesarean, mean (SD) 36.1 (14)
Risk factors
Number of older siblings, n (%)
1 165 (37.8%)
$2 72 (16.5%)
Child care, n (%) 98 (22.5%)
Maternal asthma, n (%) 49 (11.2%)
Maternal atopy*, n (%) 143 (32.8%)
Maternal smoking during pregnancy, n (%) 42 (9.6%)
Parental smoking in first y of life, n (%) 89 (20.4%)
Cesarean, n (%) 69 (15.8%)
Environmental exposure
Outdoor exposure
Distance to major roads, mean (SD) 366.1 (508.3)
Weekly mean PM10, mean (SD), mg/m
3 19.1 (9.9)
Weekly mean NO2, mean (SD), mg/m
3 15.1 (7.3)
Weekly mean temperature, mean (SD), C 9.7 (7.3)
Indoor exposure
Gas stove in the home (n = 414), n (%) 32 (7.7%)
Open fireplace in the home (n = 414), n (%) 110 (26.6%)
Educational status, n (%)
Low 118 (27%)
Middle 148 (33.9%)
High 170 (39.1%)
N, number of children; NO2, nitrogen dioxide.
*Defined as atopic asthma, atopic rhinitis, or atopic dermatitis.After restricting our sample size to those infants
27 weeks and younger, overall respiratory symptoms
were significantly lower in breastfed infants compared
with nonbreastfed ones (adjusted RR 0.70; 95% CI 0.55-
0.88; Table III). As a consequence, our later analysis
focused on respiratory symptoms during the first
27 weeks of life as a primary outcome because of the
strong age-dependent association between breastfeeding
and respiratory symptoms.
Male sex was a significant risk factor (adjusted RR 1.26;
95% CI, 1.03-1.54; Table III) for overall respiratory
symptoms during the first 27 weeks of life. By stratifying
according to breastfeeding status, the effect of male sex was
observed in breastfed infants (RR 1.52; 95% CI 1.21-1.92;
Table V), but not in nonbreastfed ones with evidence for
interaction (P value for interaction = .030). In the
sensitivity analysis, we performed the stratification by sex,
and observed the protective effect of breastfeeding only in
girls (RR 0.50; 95% CI 0.35-0.73) and not in boys (RR
0.93; 95% CI 0.68-1.27) (Table VII).
No significant association was found (Table III) between
mode of delivery and respiratory morbidity. When we
stratified by breastfeeding status, we observed a
nonsignificant reduction of overall respiratory symptoms
score in breastfed children born by cesarean (RR 0.74; 95%
CI 0.53-1.04; Table V). In contrast, in nonbreastfed infants,
the risk of having an overall respiratory symptom score
2.86 times higher was observed in the cesarean vs vaginal
delivery group (95% CI 1.53-5.34; Table V). Further, there
was significant interaction between breastfeeding and mode
of delivery on respiratory symptoms (P value for
interaction <.001).
Gestational age was not significantly associated with respi-
ratory symptoms (Table III). However, in nonbreastfed
children, significant decrease in respiratory morbidity
occurs with an increasing gestational age (RR 0.77; 95% CI
0.61-0.97). On the other hand, there was no significant
relationship between gestational age and respiratory
symptoms in breastfed children in the first 27 weeks of age
(Table V). There was significant interaction between
gestational age and breastfeeding (P value for interaction
<.001).
Smoking during the pregnancy was significantly related to
respiratory symptoms in the first 27 weeks of life (adjusted
RR 1.68; 95% CI 1.28-2.21; Table III). A stratified analysis
by breastfeeding revealed the highest risk group was those
infants who were not breastfed and whose mothers smoked
during pregnancy (RR 3.51; 95% CI 1.66-7.40). The
association between maternal smoking during pregnancy
and respiratory morbidity in breastfed infants was not
significant (Table V). In the adjusted model, the maternal
smoking  breastfeeding interaction was significant (P
value for interaction = .040; Table V) indicating a
protective effect of breastfeeding against the harmful effects
of smoking on respiratory morbidity in offspring.
The adjusted GAMM demonstrated nonsignificant posi-
tive associations of PM10 with respiratory symptoms during
Table III. Analysis of factors associated with the overall respiratory symptom score during the first 27 weeks (n = 11 365)
Variables Mean of symptom score*
Simple† model Adjustedz model
RR 95% CI P value RR 95% CI P value
Breastfeeding <.001 .002
No 0.27 1.0 Reference 1.0 Reference
Yes 0.12 0.63 0.50-0.80 0.70 0.55-0.88
Sex .009 .024
Girls 0.11 1.0 Reference 1.0 Reference
Boys 0.16 1.32 1.07-1.64 1.26 1.03-1.54
Mode of delivery .828 .680
Vaginal 0.14 1.0 Reference 1.0 Reference
Cesarean 0.13 0.97 0.72-1.30 1.06 0.81-1.39
Maternal atopy .330 .405
No 0.14 1.0 Reference 1.0 Reference
Yes 0.13 0.89 0.71-1.12 0.91 0.74-1.13
Number of older siblings <.001 <.001
0 0.08 1.0 Reference 1.0 Reference
1 0.17 1.97 1.55-2.50 1.91 1.35-2.16
$2 0.21 2.38 1.81-3.12 2.83 2.11-3.81
Child care .523 .045
No 0.14 1.0 Reference 1.0 Reference
Yes 0.15 1.08 0.85-1.38 1.27 1.01-1.61
Maternal smoking in pregnancy <.001 <.001
No 0.12 1.0 Reference 1.0 Reference
Yes 0.28 2.19 1.67-2.87 1.68 1.28-2.21
Gestational age, wk 0.13 0.98 0.89-1.07 .620 0.97 0.88-1.07 .564
PM10
x 0.13 1.13 1.05-1.22 .002 1.05 0.97-1.14 .209
n, number of wk under observation.
*Unadjusted mean of the overall symptom score.
Estimates derived from GAMM with quasi-Poisson distribution:
†Adjusted for wk of study (seasonal variation) and wk of age; and
zAdjusted for all variables in the Table and for birth weight, maternal atopy, maternal education, older siblings, child care, weekly average of temperature, wk of study (seasonal variation), wk of age,
and distance to major roads.
xRR for 10 mg/m3 increase in the level of PM10.
Table V. Association of the overall respiratory symptom score with risk factors stratified by breastfeeding status: First
27 weeks
Exposure
Breastfeeding
P value
for interactionz
Yes (n = 10 260) No (n = 1510)
Mean of
symptom score* RR† 95% CI†
Mean of
symptom score* RR† 95% CI†
Sex .029
Girls 0.08 1.0 Reference 0.31 1.0 Reference
Boys 0.15 1.52 1.21-1.92 0.23 0.73 0.43-1.24
Mode of delivery <.001
Vaginal 0.13 1.0 Reference 0.22 1.0 Reference
Cesarean 0.08 0.74 0.53-1.04 0.57 2.86 1.53-5.34
Maternal atopy .329
No 0.13 1.0 Reference 0.28 1.0 Reference
Yes 0.11 0.83 0.66-1.06 0.25 1.18 0.70-1.96
Number of older sibling .342
0 0.07 1.0 Reference 0.19 1.0 Reference
1 0.14 2.03 1.56-2.64 0.29 0.96 0.54-1.71
$2 0.19 2.44 1.80-3.32 0.43 1.55 0.74-3.23
Child care .945
No 0.12 1.0 Reference 0.26 1.0 Reference
Yes 0.13 1.17 0.90-1.52 0.29 1.58 0.84-2.96
Maternal smoking in pregnancy .040
No 0.11 1.0 Reference 0.20 1.0 Reference
Yes 0.19 1.32 0.93-1.86 0.53 3.51 1.66-7.40
Gestational age, wk 0.12 1.09 0.97-1.21 0.27 0.77 0.61-0.97 <.001
PM10
x 0.12 1.08 0.99-1.17 0.27 0.93 0.76-1.14 .101
*Unadjusted mean of the overall symptom score.
†RR and 95% CI derived from GAMM with quasi-Poisson distribution adjusted for all variables in the Table and for birth weight, maternal atopy, maternal education, older siblings, child care, weekly
average of temperature, wk of study (seasonal variation), wk of age, and distance to major roads.
zP value for interaction. Interaction was tested by adding the product between the breastfeeding and corresponding exposure in the adjusted model.
xRR for 10 mg/m3 increase in the level of PM10.
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m3 increase in PM10, respectively (Table III). The effect of
PM10 was stronger in breastfed infants than in
nonbreastfed ones (Table V), although the interaction
between breastfeeding and PM10 was not significant.Discussion
In this prospective study of healthy infants from a white Cen-
tral European middle-class population, we investigated the
effects of individual risk factors such as age, sex, hereditary
risk factors, perinatal, and environmental factors on respira-
tory symptoms in the first year of life, and the effect modifi-
cation by any breastfeeding on each of these risk factors
separately. We were able to confirm findings from other
studies that the known risk factors (male sex, older siblings,
and child care) were associated with more respiratory
symptoms.1,2,14
Maternal smoking during pregnancy and passive parental
postnatal tobacco exposure are risk factors for respiratory
symptoms in the first year of life.1,2,9,22 PM10 exposure in 
the week preceding the interview tended to be associated
with an increase in overall respiratory symptoms during
the first year of life, although not significant.8
The protective effect of breastfeeding was predominantly
seen in the first 6 months of life. This finding is consistent
with evidence from several studies in the literature,2,10,12-15 
and several hypotheses related to the mechanism have been
proposed. Most studies have associated the protective effect
of breastfeeding with lower susceptibility to viral infections.
In a few previous prospective studies, it was shown that
breastfeeding reduced the occurrence of acute respiratory
illness until up to 4 months of life.10,12,13,15 This may be 
partially explained by the higher concentration of the
immune-modulating and antiinflammatory components in
early lactation,12,30 as well as changes in the microbiota of 
breast milk.31
We found a stronger protective effect of breastfeeding in
girls than in boys. There are several studies demonstrating
that sex has an influence on the occurrence of respiratory
symptoms in breastfed children in the first year of life,16-18 
but 2 of those studies are retrospective18 and/or cross-
sectional.16 Several studies explained these phenomena by 
sex differences in early immunity (eg, by differential responses
to vaccines).17,18 Others hypothesized that human breast milk 
differently activated the immune system in boys and girls.16
The immune system is also involved in the maternal his-
tory of asthma and atopy, which are known risk factors for
subsequent wheeze in offspring.32 However, both infants of 
atopic mothers and those showing signs of atopic dermatitis
(7.3%) did not show an association with respiratory symp-
toms in the first year of life; and no evidence of interaction
between breastfeeding and maternal atopy or atopic derma-
titis of child was observed (P value >.05).
A protective effect of breastfeeding has been reported in a
first-born infant, but not in those with older siblings,19,33with the possible mechanism that increased exposure to mi-
croorganisms in infants with older siblings overwhelms the
protective effect of the breastfeeding. However, in our study
we found no evidence for interaction between breastfeeding
and number of older siblings.
We did not identify a relationship between gestational age
and respiratory symptoms during the first year of life. Previ-
ous studies reported increased risk for neonatal morbidity4
and hospitalization5 in infants delivered in the early term
period (37-38 weeks) vs the late term period ($39 weeks).
However, these studies used different definitions of outcomes
and gestational age, and studied different age periods. In our
study, respiratory symptoms increase with a decrease in
gestational age in nonbreastfed infants, but not in breastfed
ones. Thus, an interaction of gestational age and breastfeed-
ing can be postulated. The underlying mechanism of the
reduction of respiratory symptoms by breastfeeding may be
associated with immune and nonimmune factors in the
breast milk influencing the neonatal development of the
lungs.34
A novel and striking finding relates to cesarean delivery,
which is a known and poorly understood risk factor for
subsequent respiratory symptoms and asthma. Several hy-
potheses have been raised as to why cesarean birth may
be related to later respiratory symptoms. It has been postu-
lated that during vaginal delivery the immune system is spe-
cifically stimulated.35 Others have hypothesized that
bacterial colonization of the airways is modified by the birth
mode.36 Recent literature strongly focuses on the impor-
tance of the bacterial microbiome on the development of
respiratory symptoms and asthma in young children,37
and breastfeeding is known to modify the airway micro-
biome in offspring.38 We hypothesize that such mechanisms
may play a role in our finding in nonbreastfed children that
the risk of respiratory symptoms is higher after cesarean vs
vaginal delivery.
In our study, outdoor air pollution was estimated by accu-
rately measured and modeled PM10 exposure, adjusted by
season and temperature. The stratified analysis showed a
stronger, but nonsignificant effect of PM10 air pollution in
breastfed infants. This is in contrast to the findings of
Dong et al.20 Their retrospective study reported that breast-
feeding reduced the effect of PM10 on respiratory symptoms
in children 2-5 years of age. Because our findings are obser-
vational, we cannot make mechanistic inferences; however,
chemical contamination of breast milk of mothers exposed
to air pollution has been described.39-41
Few studies describe the interaction between breastfeed-
ing and maternal smoking on respiratory symptoms.20-23
In the present study, we found a modifying effect of
breastfeeding on respiratory symptoms induced by prena-
tal smoking, but not postnatal passive smoking. Further-
more, the greater adverse effect of smoking exposure in
nonbreastfed infants was observed during the prenatal,
rather than the postnatal, period. A possible explanation
linking the different effects of smoking exposure and
PM10 by breastfeeding may include the difference in
Published in final edited form as: J Pediatr. 2016 Jul;174:111-117.e5. doi: 10.1016/j.jpeds.2016.03.041tobacco and particulate matter compounds, and the time
of exposure. Future research needs to obtain information
as to when the mother was exposed to smoke while breast-
feeding, and investigate the chemical contamination of the
breast milk.
In order to study dynamic interactions between contrib-
uting factors, large datasets are needed. A prospective study
design of 436 children, each with 50-54 observations, leads
to 22 820 observed weeks. One strength of our study was
that we sought to avoid detection bias by prospectively
asking mothers weekly whether or not they are breastfeed-
ing. This allowed us to clearly define the outcomes of
breastfeeding and assess breastfeeding as a time-varying
variable. One difficulty was quantifying the addition of for-
mula supplementation (partial breastfeeding). The method
of formula feeding and introduction of solids in our
healthy group was heterogeneous and, therefore, statistical
power did not allow us to perform a subgroup analysis.
Thus, we used only the exact time point when mothers
completely weaned their children. Comparing exclusive
and nonexclusive breastfeeding could reinforce our find-
ings, given that we observed a greater benefit of breastfeed-
ing in exclusively breastfed infants.12,15,17,23 Despite the
long study period, no systematic changes in the assessment
of the exposures and outcomes were observed. A further
limitation may be the low to medium levels of air pollution
in Switzerland, which made it difficult to compare findings
with more polluted areas of the world. Whereas risk factors
were chosen a priori based on evidence from previous
studies, we did not apply a Bonferroni correction for the
number of interaction tests. Even after the Bonferroni
correction (0.05/8 interaction tests = 0.00625) the interac-
tions between breastfeeding and gestational age, and
mode of delivery remained significant.
Our study suggests that breastfeeding attenuates the effects
of risk factors such as sex, age, gestational age, cesarean deliv-
ery, and prenatal maternal tobacco smoking in healthy term
infants. In contrast, there is no evidence suggesting that
breastfeeding modifies the association of respiratory symp-
toms with maternal atopy, child care attendance, older sib-
lings, postnatal passive smoking, or PM10.
The common mechanism of the protective effects of
breastfeeding needs to be elucidated in future studies.
Possible hypotheses may relate to immune development
and susceptibility to viral infections. We found that breast-
feeding had its strongest protective effect in the first 6 months
of life, in girls, and in infants exposed to maternal tobacco
smoking. The most striking effect, however, was that infants
born by cesarean delivery may profit the most from breast-
feeding. We hypothesize that altered immune development
or development of the airway microbiota after cesarean birth
may be mechanisms of interest. Confirmation of these find-
ings in future studies could have an important impact on
health policy. n
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Appendix
Of the 436 participants, 9 observations were excluded from
the sample: 7 infants and 3 twin siblings did not complete
the 12 months of follow-up; we did not have information
about the mode of delivery, older siblings, or childcare, for
3 of the infants; and we did not have home address informa-
tion for another 3 infants. Population statistics are described
in detail in Table II. The mean duration of breastfeeding was
34.7 weeks; it was shorter in smoking mothers than in
nonsmoking mothers (Table II). Six (1.38%) infants were
not breastfed at all.
Protective Effects of Breastfeeding against the
Harmful Impact of Tobacco Exposure on
Respiratory Symptoms
A sensitivity analysis with the additional adjustment for
parental postnatal smoking exposure indicated that the effect
of maternal smoking during pregnancy on overall respiratory
symptoms was slightly attenuated in breastfed (risk ratio
[RR] 1.24; 95% CI 0.85-1.80) and nonbreastfed infants (RR
2.72; 95% CI 1.18-6.30). The interaction between breastfeed-
ing and maternal smoking in pregnancy remained significant
(P value for interaction = .044) (data not shown).
In the subgroup of the infants without maternal smoking
exposure during pregnancy (n = 402), postnatal parental
smoking was associated with a 1.35 increased risk of overall
respiratory symptom score in the first 27 weeks of life (95%
CI 1.06-1.71; Table VIII). Here, we found no evidence for
interaction between postnatal parental smoking exposure
and breastfeeding in relation to respiratory symptoms (P
value for interaction = .210; Table VIII). However, the
breastfed infants tended to have fewer respiratory
symptoms (RR 1.25; 95% CI 0.94-1.65) than nonbreastfed
ones (RR 1.76; 95% CI 0.88-3.47) (Table VIII).
Breastfeeding and Other Factors
Being in childcare and having older siblings are important
risk factors for developing respiratory symptoms in infancy
(Table III). In the interaction models, we did not find
evidence for interaction between either number of older
siblings and breastfeeding, or attending childcare and
breastfeeding, on respiratory symptoms (Table V).
We additionally performed the analysis including week of
childcare as a time-dependent variable over the entire first
year of life, we found that in the first 3 months there was a
lack of exposure (almost none of the infants were in child
care); at the end of the first year, very few infants were still
breastfeed. Thus, in order to have enough statistical power
with this type of analysis, we focussed on the time period be-
tween 12 and 36 weeks of age. In performing the analysis with
this timeframe, we produced similar results to our first anal-
ysis, where we treated (child care) as a time independent cat-
egorical variable (data not shown).
Maternal history of atopy (Table III) and maternal asthma
(data not shown) did not have an impact on respiratory
morbidity in the first year of life. There was no interaction
between breastfeeding and maternal atopy (Table V) or
maternal asthma (data not shown).
Figure 1. Schematic representation of relationship between
breastfeeding and respiratory symptoms in the first year of
life. BF represents the breastfeeding status and RS repre-
sents the overall respiratory symptoms score for each week
under observation (the possible range from 1-50/54).
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Figure 2. Flowchart of statistical analysis (first 27 weeks). Results are presented in a 2-way but congruent manner. Right side,
the results of the GAMM with quasi-Poisson distribution describing the effect of the risk factors on symptoms and their inter-
actions with BF (Table III). Left side, the association of the overall RS score with risk factors stratified by BF status (Table III).
Figure 3. Change in the risk of developing overall respiratory
symptoms during the first year of life (df = 4.24; P value
<.0001). The shaded regions denote the 95%CI. Results were
obtained from the GAMM adjusted for sex, gestational age,
mode of delivery, breastfeeding, birth weight, maternal atopy,
older siblings, child care, maternal smoking during the preg-
nancy, temperature, week of study, distance to major roads,
maternal education, and PM10.
Published in final edited form as: J Pediatr. 2016 Jul;174:111-117.e5. doi: 10.1016/j.jpeds.2016.03.041
Table IV. Analysis of factors associated with the overall respiratory symptom score during 1 year of life (n = 22 820)
Variables Mean of symptom score*
Simple† model Adjustedz model
RR 95% CI P value RR 95% CI P value
Breastfeeding .403 .605
No 0.35 1.0 Reference 1.0 Reference
Yes 0.21 0.95 0.83-1.08 0.97 0.85-1.10
Sex <.001 .001
Girls 0.22 1.0 Reference 1.0 Reference
Boys 0.29 1.32 1.18-1.49 1.22 1.09-1.38
Mode of delivery .107 .106
Vaginal 0.26 1.0 Reference 1.0 Reference
Cesarean 0.23 0.87 0.74-1.03 0.88 0.74-1.03
Maternal atopy .503 .599
No 0.26 1.0 Reference 1.0 Reference
Yes 0.24 0.96 0.84-1.09 0.97 0.86-1.09
Number of older siblings <.001 <.001
0 0.20 1.0 Reference 1.0 Reference
1 0.30 1.50 1.32-1.70 1.42 1.25-1.62
$2 0.31 1.54 1.31-1.80 1.57 1.33-1.85
Child care <.001 <.001
No 0.23 1.0 Reference 1.0 Reference
Yes 0.32 1.45 1.28-1.64 1.53 1.35-1.74
Maternal smoking in pregnancy .078 .052
No 0.25 1.0 Reference 1.0 Reference
Yes 0.30 1.18 0.98-1.43 1.21 0.99-1.47
Gestational age, wk 0.26 0.95 0.90-1.00 .051 0.95 0.90-1.002 .060
PM10
x 0.26 1.10 1.06-1.15 <.001 1.04 0.99-1.08 .087
*Unadjusted mean of the overall symptom score.
Estimates derived from GAMM with quasi-Poisson distribution:
†Adjusted for wk of study (seasonal variation) and wk of age; and
zAdjusted for all variables in the Table and for birth weight, maternal atopy, maternal education, older siblings, child care, weekly average of temperature, wk of study (seasonal variation), wk of age,
and distance to major roads.
xRR for 10 mg/m3 increase in the level of PM10.
Table I. Symptom score used in weekly phone calls*
Symptom score Daytime symptoms (cough, wheeze, or breathing difficulties) Night-time symptoms (cough, wheeze, or breathing difficulties)
0 None None
1 Slight; no treatment given Slight; sleep not disturbed
2 Required treatment but no outside help Sleep disturbed once; no help required
3 Severe; required help from GP Sleep disturbed more than once or child needed help
4 Very severe; admitted to hospital Sleep very disturbed or GP called
GP, general practitioner.
*Reprinted from Silverman et al27 with permission from BMJ Publishing Group Ltd.
Published in final edited form as: J Pediatr. 2016 Jul;174:111-117.e5. doi: 10.1016/j.jpeds.2016.03.041
Table VI. Association of the overall respiratory symptom score with risk factors stratified by breastfeeding status: 1 year
of life
Exposure
Breastfed
P value
for interactionz
Yes (n = 15 152) No (n = 7668)
Mean of
symptom score* RR† 95% CI†
Mean of
symptom score* RR† 95% CI†
Sex .014
Girls 0.16 1.0 Reference 0.32 1.0 Reference
Boys 0.24 1.40 1.21-1.63 0.37 1.03 0.86-1.24
Mode of delivery .012
Vaginal 0.22 1.0 Reference 0.35 1.0 Reference
Cesarean 0.15 0.72 0.58-0.90 0.40 1.02 0.80-1.30
Maternal atopy .372
No 0.22 1.0 Reference 0.36 1.0 Reference
Yes 0.18 0.91 0.78-1.07 0.35 1.04 0.86-1.26
Number of older siblings .754
0 0.16 1.0 Reference 0.28 1.0 Reference
1 0.24 1.51 1.27-1.79 0.40 1.34 1.10-1.64
$2 0.26 1.64 1.33-2.01 0.43 1.51 1.16-1.98
Child care .959
No 0.19 1.0 Reference 0.32 1.0 Reference
Yes 0.27 1.48 1.26-1.75 0.46 1.53 1.25-1.87
Maternal smoking in pregnancy .872
Yes 0.20 1.0 Reference 0.35 1.0 Reference
No 0.21 1.17 0.88-1.55 0.39 1.31 0.99-1.72
Gestational age, wk 0.21 1.01 0.94-1.09 0.35 0.89 0.82-0.97 .032
PM10
x 0.21 1.06 1.00-1.12 0.35 1.02 0.96-1.08 .296
n, number of wk under observation.
*Unadjusted mean of the overall symptom score.
†RR and 95% CI derived from GAMM with quasi-Poisson distribution adjusted for all variables in the Table and for birth weight, maternal atopy, maternal education, older siblings, child care, weekly
average of temperature, wk of study (seasonal variation), wk of age, and distance to major roads.
zP value for interaction. Interaction was tested by adding the product between the breastfeeding and corresponding exposure in the adjusted model.
xRR for 10 mg/m3 increase in the level of PM10.
Table VII. Adjusted association* of the overall
respiratory symptom score with the breastfeeding
stratified by sex (first 27 weeks)
Sex
Girls (n = 5426) Boys (n = 6344)
RR 95% CI P value RR 95% CI P value
Breastfeeding .0002 .629
No 1.0 Reference 1.0 Reference
Yes 0.50 0.35-0.73 0.93 0.68-1.27
*Estimates derived from GAMM with quasi-Poisson distribution adjusted for birth weight, gesta-
tional age, mode of delivery, maternal atopy, maternal education, maternal smoking during the
pregnancy, older siblings, child care, weekly average of temperature, wk of study (seasonal 
variation), wk of age, distance to major roads, and PM10.
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Table VIII. Adjusted* association of the postnatal parental smoking with overall respiratory symptom score in infants
without maternal smoking exposure during the pregnancy (N = 402) (first 27 weeks of life)
Exposure
Complete data (N = 9250)
Breastfed
P value†
Yes (n = 8127) No (n = 1123)
RR (95% CI) P value RR (95% CI) P value RR (95% CI) P value
Parental smoking in the first y of life .014 .121 .115 .206
No Reference Reference Reference
Yes 1.35 (1.106-1.71) 1.25 (0.94-1.65) 1.72 (0.88-3.37)
N, number of individuals; n, number of observations.
*Adjusted for sex, birth weight, gestational age, maternal atopy, maternal education, older siblings, child care, breastfeeding, weekly average of temperature, wk of study (seasonal component), wk
of age, distance to major roads, and PM10.
†P value for interaction. Interaction was tested by adding the product between the breastfeeding and corresponding exposure in the multivariable model.
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